ImmuneOnco Biopharmaceuticals (Shanghai) Inc

01541

Company Profile

  • Business description

    ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.

  • Contact

    1000 Zhangheng Road
    Unit 15, China (Shanghai) Pilot Free Trade Zone
    Pudong New Area
    Shanghai
    CHN

    T: +86 2138016387

    https://cn.immuneonco.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    195

Stocks News & Analysis

stocks

2 companies poised to capitalize on the rise of GLP-1 drugs

Why Pfizer and Roche look like top choices for investors in the war to tip the scales.
stocks

Does this bank have what it takes to compete with the big 4?

Organic growth and a recent acquisition were the focus of their investor day.
stocks

This ASX share is shrinking to greatness

A defensive opportunity for investors.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,915.0026.100.29%
CAC 408,108.436.31-0.08%
DAX 4024,046.0117.870.07%
Dow JONES (US)47,739.32215.67-0.45%
FTSE 1009,645.0921.92-0.23%
HKSE25,765.36319.72-1.23%
NASDAQ23,545.9032.22-0.14%
Nikkei 22550,581.9490.070.18%
NZX 50 Index13,508.8422.520.17%
S&P 5006,846.5123.89-0.35%
S&P/ASX 2008,624.4028.800.34%
SSE Composite Index3,924.0821.270.55%

Market Movers